Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 17 pseudogene 8 (KRT17P8) is a classified pseudogene related to the keratin 17 gene. Pseudogenes are DNA sequences that resemble functional genes but typically lack protein-coding capability due to disruptive mutations or lack of necessary regulatory sequences[4][5]. Pseudogenes do not make functional protein products and are generally considered non-functional “genomic fossils.” The true keratin 17 gene (KRT17) produces type I intermediate filament keratin found in several epithelial appendages and is associated with certain skin disorders, but KRT17P8, as pseudogene, has no confirmed biological function, drug interactions, disease involvement, or role as a therapeutic target[4][5]. There is no evidence that KRT17P8 encodes a receptor, enzyme, transporter, or any therapeutically relevant molecule. Its listing is likely a result of database nomenclature conventions for human keratin pseudogenes, which are numerous, generally nonfunctional, and not clinically relevant. Thus, “KRT17P8” is not appropriate for consideration as a drug target or biomarker[4][5]. Key factual points: - KRT17P8 is one of several processed keratin 17 pseudogenes present in the human genome[4][5]. - It is not protein-coding, not expressed as a functional protein, and not linked to disease or therapeutic intervention. - Keratin 17’s true protein-coding gene is “KRT17,” which is a structural protein but not a pseudogene; pseudogenes like KRT17P8, by definition, do not produce functional protein[3]. - There are multiple pseudogenes for each keratin gene, and their presence is a result of evolutionary gene duplication and mutation events[4][5]. - No aliases or alternative names beyond variations of “keratin 17 pseudogene” and the standardized abbreviation “KRT17P8” are found in current genetic databases[4][5]. If a functional keratin target is intended, the correct gene is Keratin 17 (KRT17), not KRT17P8[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 17 pseudogene 8 (KRT17P8).